Syndax wins FDA’s orphan drug designation for axatilimab in chronic lung disease
April 08 2021 - 3:49PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Syndax Pharmaceuticals (NASDAQ:SNDX)
Historical Stock Chart
From Apr 2024 to May 2024
Syndax Pharmaceuticals (NASDAQ:SNDX)
Historical Stock Chart
From May 2023 to May 2024